Large benefits to youth-focused HIV treatment-as-prevention efforts in generalized heterosexual populations: An agent-based simulation model
Open Access
- 17 December 2019
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Computational Biology
- Vol. 15 (12) , e1007561
Abstract
Predominantly heterosexual HIV-1 epidemics like those in sub-Saharan Africa continue to have high HIV incidence in young people. We used a stochastic, agent-based model for age-disparate networks to test the hypothesis that focusing uptake and retention of ART among youth could enhance the efficiency of treatment as prevention (TasP) campaigns. We used the model to identify strategies that reduce incidence to negligible levels (i.e., < 0.1 cases/100 person-years) 20–25 years after initiation of a targeted TasP campaign. The model was parameterized using behavioral, demographic, and clinical data from published papers and national reports. To keep a focus on the underlying age effects we model a generalized heterosexual population with average risks (i.e., no MSM, no PWIDs, no sex workers) and no entry of HIV+ people from other regions. The model assumes that most people (default 95%, range in variant simulations 60–95%) are “linkable”; i.e., could get linked to effective care given sufficient resources. To simplify the accounting, we assume a rapid jump in the number of people receiving treatment at the start of the TasP campaign, followed by a 2% annual increase that continues until all linkable HIV+ people have been treated. Under historical scenarios of CD4-based targeted ART allocation and current policies of untargeted (random) ART allocation, our model predicts that viral replication would need to be suppressed in 60–85% of infected people at the start of the TasP campaign to drive incidence to negligible levels. Under age-based strategies, by contrast, this percentage dropped by 18–54%, depending on the strength of the epidemic and the age target. For our baseline model, targeting those under age 30 halved the number of people who need to be treated. Age-based targeting also minimized total and time-discounted AIDS deaths over 25 years. Age-based targeting yielded benefits without being highly exclusive; in a model in which 60% of infected people were treated, ~87% and ~58% of those initiating therapy during a campaign targeting those <25 and <30 years, respectively, fell outside the target group. Sensitivity analyses revealed that youth-focused TasP is beneficial due to age-related risk factors (e.g. shorter relationship durations), and an age-specific herd immunity (ASHI) effect that protects uninfected adolescents entering the sexually active population. As testing rates increase in response to UNAIDS 90-90-90 goals, efforts to link all young people to care and treatment could contribute enormously to ending the HIV epidemic. We used an agent-based model for heterosexual epidemics to evaluate the effects of focusing treatment-as-prevention (TasP) efforts on young people. To keep the focus on age effects, we modeled populations with average risks (i.e., no MSM, no PWIDs, no sex workers). For our baseline model, we found that a long-term TasP program that focuses on HIV+ people under the age of 30 can halve the number of people who need to be treated in order to drive incidence to zero. Within the context of an overall expansion of care, we were able to identify multiple scenarios in which a successful youth-focused TasP campaign also expanded care for older people. Interestingly, we continued to see strong advantages to age-based TasP in sensitivity tests in which we removed key age-related risks (e.g., the tendency for young people to have shorter relationships). Youth-focused TasP succeeds, in large part, because it protects HIV- adolescents entering the sexually active population; i.e., a population that would otherwise be at high risk not only for getting infected but also for spreading the virus to others. This protection of adolescents leads to a steadily expanding AIDS-free generation that drives the virus to extinction.Keywords
Funding Information
- National Institute of Allergy and Infectious Diseases (R01-AI108490)
- National Institutes of Health (R21-HD075662)
- National Institutes of Health (R01-AI150467)
- National Institutes of Health (R01-HD068395)
- National Institutes of Health (R24-HD042828)
This publication has 46 references indexed in Scilit:
- Condoms in sub-Saharan AfricaSexual Health, 2012
- Determinants of Per-Coital-Act HIV-1 Infectivity Among African HIV-1–Serodiscordant CouplesThe Journal of Infectious Diseases, 2012
- Transmission Network Parameters Estimated From HIV Sequences for a Nationwide EpidemicThe Journal of Infectious Diseases, 2011
- Sexual Partnership Patterns in Malawi: Implications for HIV/STI TransmissionSexually Transmitted Diseases, 2011
- Molecular Phylodynamics of the Heterosexual HIV Epidemic in the United KingdomPLOS Pathogens, 2009
- True outcomes for patients on antiretroviral therapy who are lost to follow-up in Malawi2007
- Age-associated predictors of medication adherence in HIV-positive adults: Health beliefs, self-efficacy, and neurocognitive status.Health Psychology, 2007
- Frequency–dependent incidence in models of sexually transmitted diseases: portrayal of pair–based transmission and effects of illness on contact behaviourProceedings Of The Royal Society B-Biological Sciences, 2004
- How should pathogen transmission be modelled?Trends in Ecology & Evolution, 2001
- The Incidence and Frequency of Marital Sex in a National SampleJournal of Marriage and Family, 1995